UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000032166 |
|---|---|
| Receipt number | R000036692 |
| Scientific Title | Trial Of Onco-panel for Geneprofiling |
| Date of disclosure of the study information | 2018/04/09 |
| Last modified on | 2019/10/15 08:48:56 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Trial Of Onco-panel for Geneprofiling
Acronym
NCC Onco-panel Advanced Medical Care
Scientific Title
Trial Of Onco-panel for Geneprofiling
Scientific Title:Acronym
NCC Onco-panel Advanced Medical Care
Region
| Japan |
Condition
Condition
Malignant solid tumors or Cancer of unknown primary
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
YES
Objectives
Narrative objectives1
To estimate usefulness of multiprex genomic testing.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Detection rate of actionable genomic change.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Gene |
Interventions/Control_1
Multiplex genomic testing
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 16 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Age over 16 years
2) ECOG PS 0 to 1
3) Pathologically diagnosed as malignant solid tumor
4) Inoperable or recurrent tumor as follows
1.Cancer of unknown primary
2.Solid tumor progressed after standard chemotherapy
5) have samples for testing
4) Written informed consent
Key exclusion criteria
none
Target sample size
350
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Noboru Yamamoto |
Organization
National cancer Center Hospital
Division name
Department of Experimental Therapeutics
Zip code
Address
5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
TEL
03-3542-2511
nbryamam@ncc.go.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Natsuko Okita |
Organization
National Cancer Center Hospital
Division name
Crinical Trial Support Office
Zip code
Address
5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
TEL
03-3542-2511
Homepage URL
NCCH1616_office@ml.res.ncc.go.jp
Sponsor or person
Institute
National Cancer Center
Institute
Department
Personal name
Funding Source
Organization
Japan Agency for Medical Reserch and Development
Organization
Division
Category of Funding Organization
Government offices of other countries
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
国立がん研究センター中央病院（東京都）
国立がん研究センター東病院（千葉県）
京都大学医学部附属病院（京都府）
岡山大学病院（岡山県）
東北大学病院（宮城県）
北海道大学病院（北海道）
名古屋大学医学部附属病院（愛知県）
九州大学病院（福岡県）
慶應義塾大学病院（東京都）
神奈川県立がんセンター（神奈川県）
聖マリアンナ医科大学病院（神奈川県）
筑波大学附属病院（茨城県）
富山大学附属病院（富山県）
福井大学医学部附属病院（福井県）
名古屋市立大学病院（愛知県）
京都桂病院（京都府）
大阪赤十字病院（大阪府）
神戸市立医療センター中央市民病院（兵庫県）
和歌山県立医科大学附属病院（和歌山県）
佐賀大学医学部附属病院（佐賀県）
信州大学医学部附属病院（長野県）
兵庫県立がんセンター（兵庫県）
倉敷中央病院（岡山県）
徳島大学病院（徳島県）
国立病院機構四国がんセンター（愛媛県）
千葉県がんセンター（千葉県）
大阪医科大学附属病院（大阪府）
滋賀医科大学医学部附属病院（滋賀県）
千葉大学医学部附属病院（千葉県）
大阪市立総合医療センター（大阪府）
静岡県立総合病院（静岡県）
広島大学病院（広島県）
鳥取大学医学部附属病院（鳥取県）
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 04 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2017 | Year | 12 | Month | 28 | Day |
Date of IRB
| 2018 | Year | 01 | Month | 05 | Day |
Anticipated trial start date
| 2018 | Year | 04 | Month | 09 | Day |
Last follow-up date
| 2020 | Year | 07 | Month | 04 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2018 | Year | 04 | Month | 09 | Day |
Last modified on
| 2019 | Year | 10 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036692
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
